Literature DB >> 16377251

The health status and quality of life of adults with X-linked agammaglobulinemia.

Vanessa Howard1, Jeffrey M Greene, Savita Pahwa, Jerry A Winkelstein, John M Boyle, Mehmet Kocak, Mary Ellen Conley.   

Abstract

Forty-one adults (mean age 33) with a definitive diagnosis of X-linked agammaglobulinemia (XLA) completed a questionnaire concerning current and past medical problems and quality of life. Thirty-six of the 41 were working full time or were full time students; 18 had not missed any work or school due to infection in the previous year. Their quality of life was equivalent to that of the general US male population. Thirteen of the 41 reported that they had chronic lung disease, and 33 indicated that they had one or more episodes of sinusitis in the preceding year. Arthritis, diarrhea and skin infections were common but not debilitating. The 41 study subjects were more likely to have a prior family history of XLA, and they were more likely to have milder mutations in Btk, the gene responsible for XLA. These results indicate that most adults with XLA are moderately healthy and lead productive lives.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16377251     DOI: 10.1016/j.clim.2005.11.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  39 in total

Review 1.  Quality of life in rare genetic conditions: a systematic review of the literature.

Authors:  Julie S Cohen; Barbara B Biesecker
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

2.  Health-related quality of life (HRQL) in immunodeficient adults with selective IgA deficiency compared with age- and gender-matched controls and identification of risk factors for poor HRQL.

Authors:  G H Jörgensen; A Gardulf; M I Sigurdsson; S Arnlaugsson; L Hammarström; B R Ludviksson
Journal:  Qual Life Res       Date:  2014-03       Impact factor: 4.147

Review 3.  The genetic theory of infectious diseases: a brief history and selected illustrations.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-05-29       Impact factor: 8.929

4.  Successful hematopoietic cell transplantation in a patient with X-linked agammaglobulinemia and acute myeloid leukemia.

Authors:  Rolla F Abu-Arja; Leah R Chernin; Ghada Abusin; Jeffery Auletta; Linda Cabral; Rachel Egler; Hans D Ochs; Troy R Torgerson; Jesus Lopez-Guisa; Robert W Hostoffer; Haig Tcheurekdjian; Kenneth R Cooke
Journal:  Pediatr Blood Cancer       Date:  2015-04-20       Impact factor: 3.167

Review 5.  Toll-like receptor signaling in primary immune deficiencies.

Authors:  Paul J Maglione; Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

6.  The stable rower: identifying a rare disease.

Authors:  Tim Badcock
Journal:  Br J Gen Pract       Date:  2019-02       Impact factor: 5.386

Review 7.  Immunodeficiencies.

Authors:  M Ballow; L Notarangelo; B Grimbacher; C Cunningham-Rundles; M Stein; M Helbert; B Gathmann; G Kindle; A K Knight; H D Ochs; K Sullivan; J L Franco
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

8.  Autoimmunity and inflammation in X-linked agammaglobulinemia.

Authors:  Vivian P Hernandez-Trujillo; Chris Scalchunes; Charlotte Cunningham-Rundles; Hans D Ochs; Francisco A Bonilla; Ken Paris; Leman Yel; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2014-06-10       Impact factor: 8.317

9.  Reply.

Authors:  Lindsay E Nyhoff; Leslie J Crofford; Peggy L Kendall
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

Review 10.  Rheumatologic manifestations of primary immunodeficiency diseases.

Authors:  V R Dimitriades; R Sorensen
Journal:  Clin Rheumatol       Date:  2016-03-14       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.